Pro-Dex Inc

NASDAQ PDEX

Data sourced from iex and EODHD
Download Data

Pro-Dex Inc Free Cash Flow to Equity (FCFE) 2 year CAGR for the year ending September 20, 2024

Pro-Dex Inc Free Cash Flow to Equity (FCFE) 2 year CAGR is NA for the year ending September 20, 2024. Free Cash Flow to Equity represents the cash flow available to equity shareholders after accounting for capital expenditures and net acquisitions. It indicates the amount of cash flow that can be distributed to shareholders or reinvested in the business. It is useful in assessing the company's ability to generate cash flow for its equity investors. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
NASDAQ: PDEX

Pro-Dex Inc

CEO Mr. Richard Lee Van Kirk Jr.
IPO Date Aug. 18, 1995
Location United States
Headquarters 2361 McGaw Avenue, Irvine, CA, United States, 92614
Employees 145
Sector Healthcare
Industry Medical instruments & supplies
Description

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

StockViz Staff

September 20, 2024

Any question? Send us an email